Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Empagliflozin normalizes the size and number of mitochondria and prevents reduction in mitochondrial size after myocardial infarction in diabetic hearts

PaperCitations, authors & open-access status

Empagliflozin normalizes the size and number of mitochondria and prevents reduction in mitochondrial size after myocardial infarction in diabetic hearts is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 170 citations, 2018 year and gold oa status.

170
Citations
2018
Year
gold
OA Status

Related on ScholarIQ

Masashi Mizuno
Author
Cardiovascular Function and Risk Factors
Topic
Pancreatic function and diabetes
Topic
Cardiovascular Function and Risk Factors
Topic
Metabolism, Diabetes, and Cancer
Topic
470M+ articles · free account